S. Palmer

发表

Screening of pregnant women for evidence of current hepatitis B infection: selective or universal?

J. Banatvala, I. Chrystie, D. Sumner, 1992, Health trends.

A comparison of Rubazyme-M and MACRIA for the detection of rubella-specific IgM.

J. Best, P. Morgan-Capner, S. Palmer, 1984, Journal of virological methods.

Hepatitis A vaccine responses in HIV-positive persons with haemophilia.

A. Tilzey, M. O'Doherty, C. Harrington, 1996, Vaccine.

Should we be doing more to prevent Group C meningococcal infection in school age children? How can we decide?

A. Round, S. Palmer, 1999, Journal of public health medicine.

Prevalence of hepatitis C in tropical communities: The importance of confirmatory assays

R. Coker, J. Banatvala, S. Hojvat, 1991, Journal of medical virology.

Retrospective study of HIV, hepatitis B, and HTLV-I infection at a London antenatal clinic

J. Banatvala, I. Chrystie, S. Palmer, 1990, The Lancet.

Clinical trial with inactivated hepatitis A vaccine and recommendations for its use.

A. Safary, J. Banatvala, A. Tilzey, 1992, BMJ.

Effect of hepatitis A vaccination schedules on immune response.

A. Safary, J. Banatvala, A. Tilzey, 1992, Vaccine.

Immunity to viral infections among medical students in London

J. Best, K. Mathers, L. Hesketh, 1994, BMJ.

HIV seroprevalence among women attending antenatal clinics in London

J. Banatvala, I. Chrystie, S. Palmer, 1992, The Lancet.

False-positive serology and HIV infection

A. Voller, J. Banatvala, I. Chrystie, 1993, The Lancet.

HIV screening in pregnancy

D. Dunn, J. Banatvala, H. Stern, 1991, The Lancet.

Quantitation of HIV: Correlation with clinical, virological, and immunological status

T. Rostron, J. Banatvala, S. O'shea, 1991, Journal of medical virology.

Rubella immunity by four different techniques: results of challenge studies

J. Best, J. Banatvala, S. O'shea, 1980, Journal of medical virology.

Hepatitis B vaccine boosting among young healthy adults

J. Banatvala, A. Tilzey, WalterR. Gilks, 1994, The Lancet.